Last updated at 28 Jun 2024 09:48 PM
Director
DIN: 00021727
Uttam Amarnath Tendulkar is currently associated with 2 companies as Director. They serve as a Director at AKTIVA HERBAL PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00021727.Uttam Amarnath Tendulkar has previously been associated with 1 company in roles such as Managing Director.Uttam Amarnath Tendulkar is currently involved in 1 different role. Their most recent position is with BRIHANS PHARMACEUTICALS PRIVATE LIMITED as a Director. The first company Uttam Amarnath Tendulkar was appointed to as a director was AKTIVA HERBAL PRIVATE LIMITED. Uttam Amarnath Tendulkar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Uttam Amarnath Tendulkar is currently associated with 2 companies as Director. They serve as a Director at AKTIVA HERBAL PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 00021727.Uttam Amarnath Tendulkar has previously been associated with 1 company in roles such as Managing Director.Uttam Amarnath Tendulkar is currently involved in 1 different role. Their most recent position is with BRIHANS PHARMACEUTICALS PRIVATE LIMITED as a Director. The first company Uttam Amarnath Tendulkar was appointed to as a director was AKTIVA HERBAL PRIVATE LIMITED. Uttam Amarnath Tendulkar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
4y 5m 2y 3m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| AKTIVA HERBAL PRIVATE LIMITED | Director | 09-Feb-2004 |
| BRIHANS PHARMACEUTICALS PRIVATE LIMITED | Director | 14-Jun-2022 |